Optivia Biotechnology Inc. Appoints Dr. Jean-Michel Scherrmann To Scientific Advisory Board

Optivia Biotechnology Inc. announced today the appointment of Dr. Jean-Michel Scherrmann to the Company's Scientific Advisory Board (SAB). Dr. Scherrmann is a preeminent scientist with expertise in drug transporters in neuropharmacokinetics and drug delivery strategies to the brain.

Help employers find you! Check out all the jobs and post your resume.
MORE ON THIS TOPIC